ME
Therapeutic Areas
Tenpoint Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| BRIMOCHOL™ PF | Presbyopia | NDA Submitted |
| Undisclosed Program | Cataracts | Preclinical or Early Clinical |
| Drug | Indication | Phase |
|---|---|---|
| BRIMOCHOL™ PF | Presbyopia | NDA Submitted |
| Undisclosed Program | Cataracts | Preclinical or Early Clinical |